PubMed=1375928; DOI=10.1007/BF02877054
Eva Hellmen;
Characterization of four in vitro established canine mammary carcinoma and one atypical benign mixed tumor cell lines.
In Vitro Cell. Dev. Biol. Anim. 28:309-319(1992)

PubMed=9042250
Irma S. van Leeuwen, Eva Hellmen, Cees J. Cornelisse, Bart van der Burg, Gerard R. Rutteman;
p53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog.
Anticancer Res. 16:3737-3744(1996)

PubMed=19609018
Magdalena Krol, Karol M. Pawlowski, Janusz Stefan Skierski, Nagesha A.S. Rao, Eva Hellmen, Jan A. Mol, Tomasz Motyl;
Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential.
J. Physiol. Pharmacol. 60 Suppl. 1:95-106(2009)

PubMed=20453304; DOI=10.1007/BF03195725
Magdalena Krol, Karol M. Pawlowski, Janusz Stefan Skierski, Pawel Turowski, Alicja Majewska, Joanna Polanska, Maciej Ugorski, Rory E. Morty, Tomasz Motyl;
Transcriptomic 'portraits' of canine mammary cancer cell lines with various phenotypes.
J. Appl. Genet. 51:169-183(2010)

PubMed=22235976; DOI=10.1111/j.1476-5829.2011.00269.x
Karol M. Pawlowski, Donald T. Popielarz, Katarzyna Szyszko, Malgorzata Gajewska, Tomasz Motyl, Magdalena Krol;
Growth hormone receptor (GHR) RNAi decreases proliferation and enhances apoptosis in CMT-U27 canine mammary carcinoma cell line.
Vet. Comp. Oncol. 10:2-15(2012)